[ad_1]
In recent months, the AstraZeneca laboratory, in conjunction with the University of Oxford in the United Kingdom, have been in search of a coronavirus vaccine. So far, it has been considered as one of the most promising solutions.
Hundreds of volunteers around different countries have been part of clinical trials for the eventual approval of the vaccine, However, the process has not been without its difficulties.
According to a recently released AstraZeneca report, a second volunteer presented adverse symptoms related to a neurological disorder. It would be a 37-year-old woman, previously healthy, who “experienced transverse myelitis” after receiving your second dose of the vaccine, thus being hospitalized on September 5.
According to what was reported by The New York Times, the document, dated September 10, describes how the participant had trouble walking, as well as weakness and pain in the arms, along with other symptoms.
Last week, the laboratory had announced the “unexplained illness” of the volunteer, which caused rehearsals to be paused around the world.
However, the report indicates that it is unlikely that the diseases, in both the first and second cases, were associated with the vaccine and that there is no certainty that these are related to them.
